Innovative Therapies Days 2023 - 3eme édition
Informations pratiques
12 au 13 oct. 2023 de 8 h à 18 h
Kursaal, 2 Pl. du Théâtre, 25000 Besançon
Les 12 et 13 octobre, la troisième édition des INNOVATIVE THERAPIES DAYS - ITD
INNOVATIVE THERAPIES DAYS 2023
Les 12 et 13 octobre, la troisième édition des INNOVATIVE THERAPIES DAYS se tiendra à Besançon (25), en France.
« INNOVATIVE THERAPIES DAYS » est le symposium clé qui donnera une large place aux échanges entre experts dans leur domaine. Avec quelques partenaires nationaux et internationaux et environ 400 visiteurs, ITD réunit scientifiques, pharmaciens, cliniciens et partenaires industriels pour 2 jours de conférences de haut niveau sur les cellules CAR-T, les thérapies cellulaires, les thérapies innovantes dérivées de cellules et la réglementation, la production et le transfert clinique de thérapies innovantes.
Si la région Bourgogne-Franche-Comté est le berceau des micro-technologies, c’est la combinaison de ces technologies avec les thérapies cellulaires, qui a permis à l’institut RIGHT de sortir des produits phares comme les cellules CAR-T !
Enregistrez-vous ici !
AU PROGRAMME
AU PROGRAMME :
WEDNESDAY, OCTOBER 11TH
- 17:00-21:00 : WELCOME EVENING (BIO INNOVATION)
RIGHT Institute students present scientific posters, visit Bio Innovation and discover the regional biocluster.
THURSDAY, OCTOBER 12TH
- 8:30 : REGISTRATION AND WELCOME COFFEE (KURSAAL BALLROOM)
- 9:00 : WELCOME ADRESS AND INTRODUCTION (KURSAAL)
Dr. Sylvain Perruche, RIGHT Institute, Besançon, FR
Renaud Gaudillière, PMT director, Besançon, FR
Representative of the President of Grand Besançon Métropole
Representative of the President of the Bourgogne Franche Comté Region
09:20-12:30 : SESSION #1 « UPCOMING INNOVATIVE THERAPIES »
Chairpersons : Dr. Christelle Monville, I-Stem, Evry and Dr. Sylvain Perruche, RIGHT Institute, Besançon, FR
- 09:20 : CELLS OR SECRETOME FOR THE TREATMENT OF HEART FAILURE ?
Prof. Dr. Philippe Menasché, INSERM U970 – Hôpital Européen Georges Pompidou, Paris, France
- 09:55 : IMMUNE SECRETOMES TARGETING AGE-ACQUIRED IMMUNE DECLINE
Dr. Hans Keirstead, Immunis, Irvine, USA
- 10:30 : BREAK – EXHIBITION HALL
- 11:15 : THE CLINICAL TRANSLATION OF ST266, A NOVEL AMNION CELL-DERIVED SECRETOME
Dr. Larry Brown, Noveome Biotherapeutics, Pittsburg, USA
- 11:45 : MACROPHAGE THERAPY FOR LIVER DISEASES, TITLE TO BE ANNOUNCED
Dr. Victor Dillard, Resolution Therapeutics, Edinburgh, UK
- 12:15-14:00 : LUNCH
- 13:00-14:30 : Exhibition Hall – B2B MEETINGS
- 14:00-14:30 : EFS SYMPOSIUM
Selected oral presentation from PhD students from the RIGHT Institute, Besançon, FR
14:30-18:00 : SESSION #2 “CAR TECHNOLOGY: FROM CAR-T TO CAR-NK”
Chairpersons: Dr. Marina Deschamps and Dr. Christophe Ferrand, RIGHT institute, Besançon, FR
- 14:30 : ALLOGENEIC CAR T-CELLS FOR ADOPTIVE CELL THERAPY
Dr. Mark Frattini, Cellectis, New-York, USA
- 15:00 : HIGH EFFECTIVENESS AND SAFETY OF ANTI-CD7 CAR T-CELL THERAPY IN TREATING RELAPSED OR REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)
Peihua (Peggy) Lu, MD, Lu Daopei Hospital and Beijing Lu Daopei Institute of Hematology, China
- 15:30 : ENABLING MANUFACTURING OF GENE-EDITING CELL THERAPIES
Dr. Mélanie Rietenbach, Miltenyi Biotech, Düsseldorf, Germany
- 16:00 : BREAK – EXHIBITION HALL
- 16:45 : DEVELOPMENT OF ALLOGENEIC CAR-T CELLS BASED ON T CELL PROGENITORS
Dr. Olivier Negre, Smart Immune, Paris, France
- 17:15 : NATURAL KILLER CELLS – ENGINEERED TO BEAT CANCER
Dr. Ralph Brandenberger, Nkarta Therapeutics, San Francisco, USA
- 18:00-19:30 : B2B MEETINGS OR VISIT OF BESANÇON
- 19:30 : COCKTAIL (on registration only)
- 20:00 : EVENING RECEPTION (on registration only)
FRIDAY, OCTOBER 13TH
- 8:30 : WELCOME COFFEE
- 08:30-09:15 : EXHIBITION HALL – B2B MEETINGS
09:15 – 12:00 : SESSION #3 “PATHWAYS FOR INNOVATIVE THERAPIES”
Chairpersons :Dr.Olivier Humbey, IQVIA, Dijon and Dr. Mathieu Guerriaud, CREDIMI, Dijon, FR
- 09:15 : PIPELINE ANALYSIS OF CELL AND GENE THERAPY PRODUCTS
Dr. Gavin Yirajen Vuddamalay, Mabdesign, Lyon, France
- 09:45 : EU SUPPORT AND INCENTIVES FOR INNOVATIVE DRUG DEVELOPMENT: OVERVIEW OF THE REGULATORY ADVICE TOOLBOX AND TREND ANALYSIS
Dr. Oriane Blanquie, European Medicines Agency, Amsterdam, Netherlands
- 10:15 : BREAK- EXHIBITION HALL
- 11:00 : HOW CAN CELL AND GENE THERAPIES OVERCOME CURRENT MARKET ACCESS CHALLENGES TO DELIVER ON THEIR PROMISE ?
Dr. Christopher Ball, IQVIA, London, UK
- 11:30 : DIGITAL SOLUTIONS TO SECURE YOUR BIOPROCESS: EFFICIENT FACILITY DESIGN AND ACCELERATED OPERATOR COMPETENCY – A RD-BIOTECH CASE STUDY
Kajsa Löwenhielm, Cytiva, Amersham, UK and Dr. Jean-Luc Schlick, RD-Biotech, Besançon, FR
- 12:00-14:00 : LUNCH
- 12:40-14:00 : Exhibition Hall – B2B MEETINGS
14:00-16:30 : SESSION #4 “CELL AND GENE THERAPIES”
Chairpersons :Dr. Fanny Delettre, EFS,andDr. Jean-Luc Schlick, RD-Biotech, Besançon, FR
- 14:00 : OVERVIEW OF CELL AND GENE THERAPY IN ANIMAL HEALTH
Dr. Michael Donabedian, Vetoquinol, Lure, France
- 14:30 : HOSPITAL EXEMPTION AS ALTERNATIVE TO SUCCEED IN ATMPS DEVELOPMENT : THE EXAMPLE OF THE ADICROHN PROJECT
Dr. Jérémy Magalon, AP-HM, Marseille, France
- 15:00 : BREAK – EXHIBITION HALL
- 15:30 : RETINAL PIGMENT EPITHELIAL CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS DISPOSED ON HUMAN AMNIOTIC MEMBRANE: AN UPDATE ON THE FRENCH RP CLINICAL TRIAL
Dr. Christelle Monville, I-Stem, Evry, France
- 16:00 : HUMAN CD34+ CELLS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE
Dr. Ibon Garitaonandia, CellProthera, Mulhouse, France
- 16:30-16:45 : CONCLUSION END OF CONGRESS
Dr. Christophe Ferrand, RIGHT Institute, Besançon, FR
Renaud Gaudillière, PMT director, Besançon, FR
- 16:45–17:45 : B2B MEETINGS
- 16:45-18:00 : BEER PARTY
Linkedin : @innovativetherapiesdays
Pour en savoir plus sur le programme, les partenaires et les détails, consultez le siteInformations pratiques
12 au 13 oct. 2023 de 8 h à 18 h
Kursaal, 2 Pl. du Théâtre, 25000 Besançon